Orthopoxvirus Vaccine Group - May 2022 Emergency Use Authorization (EUA) for Mpox
Orthopoxvirus Vaccine Group Evaluation and Forecasting Rules
General Rules for Orthopoxvirus - EUA
General rules are not series-specific; general rules apply to the entire vaccine group.
Recommendation Rules
If the patient has no dose (valid shot) on record, recommendation is Conditional with reason code HIGH_RISK.
Orthopoxvirus Vaccines
CVX Code | Name | Absolute Minimum Age |
---|---|---|
751 | vaccinia (smallpox) vaccine (ACAM2000) | 1 year - 4 days |
1051 | vaccinia (smallpox) vaccine, diluted (Inactive; not preferred) | 1 year - 4 days |
2061 | Vaccinia, smallpox mpox vaccine live, PF (JYNNEOS) | 0 days |
Combination Vaccines that Include Orthopoxvirus
No combination vaccines exist, at this time, that include Orthopoxvirus.
CVX Code Specific Rules
- The Live Vaccine Interval rule is not enforced for evaluation of Orthopoxvirus - May 2022 EUA, but is considered for the forecast date.1
1 Information about dosing intervals for inadvertently administered doses below the minimum interval is available at https://www.cdc.gov/poxvirus/mpox/interim-considerations/jynneos-vaccine.html#dosing.
Immunization Series and Selection Rules - EUA
Series Name
- Orthopoxvirus 2-Dose Series (May 2022 EUA)
- Orthopoxvirus 1-Dose Series (May 2022 EUA)
Series Selection Rules
There are two series for this vaccine group: the Orthopoxvirus 2-Dose Series (May 2022 EUA) and the Orthopoxvirus 1-Dose Series (May 2022 EUA). The rules for determining which series applies are:
If a CVX 75 or CVX 105 dose is administered for dose 1, the Orthopoxvirus 1-Dose Series (May 2022 EUA) applies.
If a CVX 206 dose is administered for dose 1, the Orthopoxvirus 2-Dose Series (May 2022 EUA) applies.
- If a CVX 75 or CVX 105 is administered on the same day as a Valid CVX 206 for target dose 1, the Orthopoxvirus 2-Dose Series (May 2022 EUA) applies.
- Evaluate the CVX 75 or CVX 105 as Invalid with reason code DUPLICATE_SAME_DAY.
Immunization Series: Orthopoxvirus 2-Dose Series (May 2022 EUA)
The Orthopoxvirus 2-Dose Series (May 2022 EUA) is complete after 2 doses.
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum Age | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Orthopoxvirus 2-Dose Series (May 2022 EUA) | 0 days | 18 years | 18 years | N/A | 206 | N/A |
2 | Orthopoxvirus 2-Dose Series (May 2022 EUA) | N/A | N/A | N/A | N/A | 206, 75, 105 | N/A |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Orthopoxvirus 2-Dose Series (May 2022 EUA) | 1 day | 28 days | 28 days | N/A |
Series Special Rules
Series Evaluation Special Rules
The series is complete after 2 doses.
Recommend CVX 206 at the vaccine level for target dose 2.
If the 2nd shot is administered below the minimum interval or live virus interval, evaluate the shot as Valid with reason code SUPPLEMENTAL_TEXT and descriptive text: “The interval between this dose and the prior shot is less than the minimum interval. The dose does not need to be repeated unless the patient is severely immunosuppressed, in which case the repeated dose should be administered after the dose given in error by at least 28 days.”
If an additional shot is administered after the series is complete, evaluate it as Valid. Evaluate all additional shots afterwards as Accepted / EXTRA_DOSE.
Immunization Series: Orthopoxvirus 1-Dose Series (May 2022 EUA)
The Orthopoxvirus 1-Dose Series (May 2022 EUA) is complete after 1 dose.
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum Age | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Orthopoxvirus 1-Dose Series (May 2022 EUA) | 1 year - 4 days | N/A | N/A | N/A | 75, 105 | N/A |
Series Special Rules
Series Evaluation Special Rules
The series is complete after 1 dose.
If an additional shot is administered after the series is complete, evaluate it as Valid. Evaluate all additional shots afterwards as Accepted / EXTRA_DOSE.